Lawrence Baker

1.6k total citations
40 papers, 1.0k citations indexed

About

Lawrence Baker is a scholar working on Economics and Econometrics, Health and General Health Professions. According to data from OpenAlex, Lawrence Baker has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 7 papers in Health and 6 papers in General Health Professions. Recurrent topics in Lawrence Baker's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), COVID-19 epidemiological studies (6 papers) and Vaccine Coverage and Hesitancy (5 papers). Lawrence Baker is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), COVID-19 epidemiological studies (6 papers) and Vaccine Coverage and Hesitancy (5 papers). Lawrence Baker collaborates with scholars based in United States, United Kingdom and Portugal. Lawrence Baker's co-authors include John J. Crowley, Agnieszka Woźniak, KS Albain, R. B. Livingston, Geoffrey R. Weiss, C. Harris Spiridonidis, Karen Kelly, S P Balcerzak, David R. Gandara and Anita Mansouri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lawrence Baker

36 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Baker United States 13 561 538 186 175 122 40 1.0k
Taha Koray Şahin Türkiye 18 561 1.0× 270 0.5× 200 1.1× 126 0.7× 143 1.2× 83 1.1k
Sophie Papa United Kingdom 23 952 1.7× 287 0.5× 281 1.5× 138 0.8× 120 1.0× 57 1.8k
Andrea Tavilla Italy 10 584 1.0× 289 0.5× 77 0.4× 269 1.5× 216 1.8× 16 1.2k
Benjamin A. Gartrell United States 17 823 1.5× 586 1.1× 335 1.8× 64 0.4× 247 2.0× 74 1.4k
E. Neely Atkinson United States 16 500 0.9× 469 0.9× 450 2.4× 106 0.6× 315 2.6× 28 1.6k
Brian S. Finkelman United States 18 596 1.1× 182 0.3× 258 1.4× 231 1.3× 167 1.4× 50 1.4k
Lucie Biard France 22 260 0.5× 560 1.0× 112 0.6× 202 1.2× 115 0.9× 74 1.4k
Fabrizio Stracci Italy 19 580 1.0× 137 0.3× 127 0.7× 160 0.9× 166 1.4× 67 1.1k
Alice Indini Italy 23 999 1.8× 355 0.7× 371 2.0× 211 1.2× 243 2.0× 82 1.7k

Countries citing papers authored by Lawrence Baker

Since Specialization
Citations

This map shows the geographic impact of Lawrence Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Baker more than expected).

Fields of papers citing papers by Lawrence Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Baker. The network helps show where Lawrence Baker may publish in the future.

Co-authorship network of co-authors of Lawrence Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Baker. A scholar is included among the top collaborators of Lawrence Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Baker. Lawrence Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulcahy, Andrew, et al.. (2025). Use of Clinical Trial Characteristics to Estimate Costs of New Drug Development. JAMA Network Open. 8(1). e2453275–e2453275. 5 indexed citations
2.
Baker, Lawrence, et al.. (2025). Cognitively-plausible reinforcement learning in epidemiological agent-based simulations. PubMed. 5. 1563731–1563731.
3.
Baker, Lawrence & Renea Sturm. (2024). Mortality in extreme heat events: an analysis of Los Angeles County Medical Examiner data. Public Health. 236. 290–296. 1 indexed citations
4.
Timbie, Justin W., et al.. (2024). Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases. Journal of Comparative Effectiveness Research. 13(9). e240078–e240078. 2 indexed citations
5.
Liu, Jodi, et al.. (2024). Geographic variation in shortfalls of dementia specialists in the United States. Health Affairs Scholar. 2(7). qxae088–qxae088. 3 indexed citations
6.
Al–Rubaye, Saba, et al.. (2024). Federated Deep Reinforcement Learning-Based Intelligent Surface Configuration in 6G Secure Airport Networks. IEEE Transactions on Intelligent Transportation Systems. 26(10). 17304–17320. 5 indexed citations
7.
Liu, Jodi, Lawrence Baker, Annie Chen, Jessie Wang, & Federico Girosi. (2024). Modeling Early Detection and Geographic Variation in Health System Capacity for Alzheimer’s Disease‐Modifying Therapies. Alzheimer s & Dementia. 20(S7). 2 indexed citations
8.
Liu, Jodi, Lawrence Baker, Annie Chen, Jessie Wang, & Federico Girosi. (2024). Modeling Early Detection and Geographic Variation in Health System Capacity for Alzheimer's Disease–Modifying Therapies. RAND Corporation eBooks. 1 indexed citations
9.
Olivotto, Iacopo, Teofila Bueser, Pablo García‐Pavía, et al.. (2024). Family matters: health policies to tackle cardiomyopathies across Europe. European Heart Journal. 46(1). 6–14. 1 indexed citations
10.
Berdahl, Carl T., et al.. (2023). Strategies to Improve the Impact of Artificial Intelligence on Health Equity: Scoping Review. SHILAP Revista de lepidopterología. 2. e42936–e42936. 26 indexed citations
11.
Berdahl, Carl T., et al.. (2022). Artificial intelligence applications used in the clinical response to COVID-19: A scoping review. SHILAP Revista de lepidopterología. 1(10). e0000132–e0000132. 15 indexed citations
12.
Faherty, Laura J., Jeanne S. Ringel, Ashley M. Kranz, et al.. (2022). The U.S. Equity-First Vaccination Initiative: Impacts and Lessons Learned. RAND Corporation eBooks. 10(2). 3–3. 2 indexed citations
13.
Lima, Pedro Nascimento de, Robert J. Lempert, Raffaele Vardavas, et al.. (2021). Reopening California: Seeking robust, non-dominated COVID-19 exit strategies. PLoS ONE. 16(10). e0259166–e0259166. 10 indexed citations
14.
Baker, Lawrence, et al.. (2021). Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results. INQUIRY The Journal of Health Care Organization Provision and Financing. 58. 20 indexed citations
15.
Maley, Jason H., Lawrence Baker, Susana M. Vieira, et al.. (2021). Data-driven curation process for describing the blood glucose management in the intensive care unit. Scientific Data. 8(1). 80–80. 12 indexed citations
16.
Baker, Lawrence, et al.. (2020). Real-world characterization of blood glucose control and insulin use in the intensive care unit. Scientific Reports. 10(1). 10718–10718. 21 indexed citations
17.
Cooper, Sophie, Jacoline C. Bouvy, Lawrence Baker, et al.. (2020). How should we assess the clinical and cost effectiveness of histology independent cancer drugs?. BMJ. 368. l6435–l6435. 17 indexed citations
18.
Woźniak, Agnieszka, John J. Crowley, S P Balcerzak, et al.. (1998). Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.. Journal of Clinical Oncology. 16(7). 2459–2465. 462 indexed citations
19.
McCracken, Joseph D., John J. Crowley, Padmini Giri, et al.. (1990). Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.. Journal of Clinical Oncology. 8(5). 892–898. 138 indexed citations
20.
Baker, Lawrence, et al.. (1977). Phase II study of 5-azacytidine in solid tumors.. PubMed. 61(1). 51–4. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taha Koray Şahin Breakdown of academic impact, for papers by Sophie Papa Breakdown of academic impact, for papers by Andrea Tavilla Breakdown of academic impact, for papers by Benjamin A. Gartrell Breakdown of academic impact, for papers by E. Neely Atkinson Breakdown of academic impact, for papers by Brian S. Finkelman Breakdown of academic impact, for papers by Lucie Biard Breakdown of academic impact, for papers by Fabrizio Stracci Breakdown of academic impact, for papers by Alice Indini
Rankless by CCL
2026